Karoly Szuhai Selected Research

Karoly Szuhai Research Topics

Disease

32	Neoplasms (Cancer) 10/2022 - 03/2006
9	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 02/2007
7	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 11/2009
6	Chordoma 01/2021 - 02/2011
6	Ewing Sarcoma (Sarcoma, Ewing) 11/2020 - 01/2012
5	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2010
4	Carcinogenesis 09/2021 - 02/2012
3	Chondrosarcoma 12/2020 - 07/2006
3	Carcinoma (Carcinomatosis) 07/2015 - 12/2006
3	Adenocarcinoma 12/2006 - 04/2006
2	Chromosomal Instability (Chromosome Stability) 01/2022 - 12/2006
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 09/2013
2	Melanoma (Melanoma, Malignant) 11/2019 - 01/2017
2	Synovial Sarcoma (Synovioma) 01/2019 - 01/2018
2	Testicular Neoplasms (Testicular Cancer) 01/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 07/2015 - 01/2005
2	Colonic Neoplasms (Colon Cancer) 01/2009 - 01/2007
1	Giant Cell Tumors (Giant Cell Tumor) 01/2022
1	Bone Cysts (Bone Cyst) 12/2021
1	Infertility (Sterility) 01/2021
1	Chondroblastoma 01/2020
1	Brain Neoplasms (Brain Tumor) 11/2019
1	Leiomyosarcoma 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	Hemangioendothelioma 01/2018
1	Genomic Instability 01/2017
1	Rupture 01/2017
1	Uveal melanoma 01/2017
1	Mesenchymal Chondrosarcoma 10/2016
1	Aneurysm (Aneurysms) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Abdominal Aortic Aneurysm 01/2016
1	Carcinosarcoma 07/2015
1	Mental Disorders (Mental Disorder) 05/2014
1	Fibroma (Fibromatosis) 05/2014
1	Multiple Myeloma 09/2013
1	Monosomy 09/2013
1	Sensorineural Hearing Loss 06/2013
1	Osteoma 01/2013
1	Osteoblastoma 01/2013

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2006
6	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
4	RNA (Ribonucleic Acid)IBA 12/2018 - 04/2006
4	Messenger RNA (mRNA)IBA 01/2018 - 03/2009
4	Brachyury protein (Brachyury)IBA 09/2017 - 02/2011
4	Transcription Factors (Transcription Factor)IBA 09/2017 - 02/2011
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2015
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2021 - 01/2018
2	LigandsIBA 01/2021 - 04/2011
2	AntigensIBA 01/2018 - 01/2017
2	Phosphotransferases (Kinase)IBA 09/2017 - 09/2010
2	nutlin 3IBA 08/2014 - 09/2011
1	Monoclonal AntibodiesIBA 10/2022
1	palbociclibIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2020
1	Insulin (Novolin)FDA Link 11/2020
1	Insulin ReceptorIBA 11/2020
1	Histones (Histone)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2019
1	telatinibIBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	matrigelIBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	tyrosine receptor (receptor, tyrosine)IBA 09/2017
1	ActomyosinIBA 01/2017
1	ABT-737IBA 10/2016
1	Oncogene Proteins (Oncogene Protein)IBA 02/2016
1	paricalcitol (Zemplar)FDA Link 01/2016
1	CalcineurinIBA 01/2016
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2015
1	olaparibIBA 07/2015
1	CD27 LigandIBA 01/2015
1	Proto-Oncogene Proteins c-etsIBA 08/2014
1	cyclo(cysteinyl- tyrosyl- norleucyl- glycyl- tryptophyl- cysteinyl)- aspartyl- phenylalaninamide (Es1)IBA 08/2014
1	YK 4-279IBA 08/2014
1	Glutamic Acid (Glutamate)FDA Link 05/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2014
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2013
1	Connexin 26IBA 06/2013
1	ConnexinsIBA 06/2013
1	beta CateninIBA 01/2013
1	NucleotidesIBA 11/2012
1	Biological ProductsIBA 10/2012
1	ParaffinIBA 05/2012

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2007
7	Drug Therapy (Chemotherapy) 12/2020 - 03/2009
4	Immunotherapy 01/2017 - 01/2012
4	Ligation 09/2013 - 03/2007
2	Subcutaneous Injections 01/2022 - 03/2021
1	Investigational Therapies (Experimental Therapy) 11/2019
1	Stem Cell Transplantation 01/2018
1	Combined Modality Therapy 02/2016
1	Operative Surgical Procedures 02/2012